Vanguard Asset Management »

Arbutus Biopharma shares owned by Vanguard Asset Management

Quarter-by-quarter ownership of Arbutus Biopharma (ABUS) shares owned by Vanguard Asset Management from 13F filings

Historical chart of Vanguard Asset Management investment in Arbutus Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arbutus Biopharma held by Vanguard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arbutus Biopharma by Vanguard Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $403k 90k 4.50

More positions owned by Vanguard Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Astrazeneca Ord (AZN)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Johnson & Johnson (JNJ)

View all positions for Vanguard Asset Management

Top funds holding Arbutus Biopharma

Morgan Stanley
Two Seas Capital
Whitefort Capital Management
BlackRock
Vanguard Group
Vanguard Capital Management
Rubric Capital Management
State Street Corporation
Adage Capital Partners GP
Geode Capital Management
ADAR1 Capital Management
Legal & General Group
Woodline Partners
Leucadia National Corporation
BlackBarn Capital Partners

View all funds holding Arbutus Biopharma